Literature DB >> 6209991

Differences in brain serotonergic metabolism between nonbulimic and bulimic patients with anorexia nervosa.

W H Kaye, M H Ebert, H E Gwirtsman, S R Weiss.   

Abstract

CSF concentrations of serotonin and dopamine metabolites in 16 patients with anorexia nervosa were measured before and after probenecid administration, and the patients were studied before and at intervals after weight recovery. After probenecid administration, the weight-recovered nonbulimic anorexic patients had a higher concentration of the serotonin metabolite, 5-hydroxyindoleacetic acid, than the weight-recovered bulimic patients but no significant differences in CSF homovanillic acid. This finding is consistent with evidence that suggests a role for brain serotonin metabolism in carbohydrate and mood regulation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6209991     DOI: 10.1176/ajp.141.12.1598

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  12 in total

Review 1.  Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder.

Authors:  S Krüger; S H Kennedy
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 2.  Is anorexia nervosa a neuropsychological disease?

Authors:  C M Braun; M J Chouinard
Journal:  Neuropsychol Rev       Date:  1992-06       Impact factor: 7.444

3.  Altered implicit category learning in anorexia nervosa.

Authors:  Megan E Shott; J Vincent Filoteo; Leah M Jappe; Tamara Pryor; W Todd Maddox; Michael D H Rollin; Jennifer O Hagman; Guido K W Frank
Journal:  Neuropsychology       Date:  2011-12-26       Impact factor: 3.295

Review 4.  Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans.

Authors:  M A van Gestel; E Kostrzewa; R A H Adan; S K Janhunen
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

Review 5.  Aetiopathogenesis and pathophysiology of bulimia nervosa: biological bases and implications for treatment.

Authors:  F Brambilla
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

6.  Tumour necrosis factor production and cell-mediated immunity in anorexia nervosa.

Authors:  A Schattner; M Steinbock; R Tepper; A Schonfeld; N Vaisman; T Hahn
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

7.  Evidence for a susceptibility gene for anorexia nervosa on chromosome 1.

Authors:  D E Grice; K A Halmi; M M Fichter; M Strober; D B Woodside; J T Treasure; A S Kaplan; P J Magistretti; D Goldman; C M Bulik; W H Kaye; W H Berrettini
Journal:  Am J Hum Genet       Date:  2002-01-17       Impact factor: 11.025

8.  Serotonin turnover in rat brain during semistarvation with high-protein and high-carbohydrate diets.

Authors:  U Schweiger; A Broocks; R J Tuschl; K M Pirke
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

Review 9.  Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities.

Authors:  J L Jarry; F J Vaccarino
Journal:  J Psychiatry Neurosci       Date:  1996-01       Impact factor: 6.186

Review 10.  Eating disorders and the serotonin connection: state, trait and developmental effects.

Authors:  Howard Steiger
Journal:  J Psychiatry Neurosci       Date:  2004-01       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.